Concepedia

Juergen Jauernig

JJ

4

Publications

159

Citations

4

H-Index

2005

Active since

Affiliations

Novartis (Switzerland)(Current)

Juergen Jauernig is an author at Novartis (Switzerland) specializing in asthma, pulmonary medicine, and medicine.

Top concepts

Publications per year

2005–2020

4

Publications

4

Delivery characteristics of a low-resistance dry-powder inhaler used to deliver the long-acting muscarinic antagonist glycopyrronium

Paul Colthorpe, Thomas Voshaar, Thomas Kieckbusch et al. · Journal of Drug Assessment · 2013 · 73 citations · Full text

<i>In Vitro</i> Determination of the Optimal Particle Size for Nebulized Aerosol Delivery to Infants

Karen G. Schüepp, Juergen Jauernig, Hettje M. Janssens et al. · Journal of Aerosol Medicine · 2005 · 64 citations

Position paper: recommendation on the adoption of breathing patterns for infants and small children in general chapter 2.9.44. Preparations for nebulisation.

Juergen Jauernig, Julia Mitchell, E Berg et al. · PubMed · 2008 · 11 citations

, , +17

Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate following once-daily inhalation as a combination in healthy subjects

Soniya Vaidya, Juergen Jauernig, Brian Ethell et al. · Pulmonary Pharmacology & Therapeutics · 2020 · 11 citations · Full text

, , +15

Rows per page

1–4 of 4